Key facts about Bromocriptine Mesylate
What dosages is Bromocriptine Mesylate available in?
Bromocriptine Mesylate is available as a 0.8 mg oral tablet.
What is Bromocriptine Mesylate used for?
Bromocriptine Mesylate is a dopamine agonist and is used to treat type 2 diabetes.
How does Bromocriptine Mesylate work?
Bromocriptine Mesylate is a dopamine agonist. It activates (turns on) dopamine receptors to lower fasting and high blood sugar levels after the meals you eat during the day. It also helps improve insulin sensitivity and the removal of sugars from your body.
How do I take Bromocriptine Mesylate?
The starting dose is 0.8 mg by mouth once daily, taken within 2 hours of waking up in the morning. Your provider will raise your dose each week by 0.8 mg until the recommended dose of 1.6 mg to 4.8 mg per day is reached.
Is it safe for me to take Bromocriptine Mesylate?
Bromocriptine Mesylate is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication in the following:
- Do not use in patients with hypersensitivity to ergot-related drugs, bromocriptine or to any of the excipients in Bromocriptine Mesylate
- Do not use in patients with syncopal migraines. May precipitate hypotension
- Do not use in nursing women. May inhibit lactation. Postmarketing reports of stroke in this patient population
Bromocriptine Mesylate Common Side Effects
Common side effects of Bromocriptine Mesylate:
- Nausea
- Stuffy nose
- Headache
- Dizziness
- Lack of energy
- Constipation
- Sinus infection
Bromocriptine Mesylate Serious Side Effects
Serious side effects are rare with Bromocriptine Mesylate. Contact your healthcare provider immediately if you experience any of the following.
- Low blood pressure: tiredness, severe dizziness, fainting
Effects of other drugs, drug classes and over-the-counter products on Bromocriptine Mesylate
The following medications may interact with Bromocriptine Mesylate:
- May increase the unbound fraction of highly protein-bound therapies altering their effectiveness and safety profiles
- May increase ergot-related side effects or reduce ergot effectiveness for migraines if co-administered within 6 hours of ergot-related drugs
- Extensively metabolized by CYP3A4. Use caution when coadministering strong inhibitors, inducers, or substrates for CYP3A4
Who makes Bromocriptine Mesylate?
Various FDA-approved generic manufacturers
Is Bromocriptine Mesylate safe in pregnancy?
It is not known if Bromocriptine Mesylate will harm your unborn baby. Talk with your healthcare provider if you are pregnant or plan to become pregnant.
